LSEG’s Marcus Stuttard speaks to Dr Gordon Sanghera, CEO and co-founder of Oxford Nanopore Technologies, on why they decided after 15 years it was the right time to launch their IPO, and how going public has freed their time to focus on innovation.

Oxford Nanopore Technologies develops and commercialises sensing technology that uses nanopores - nano-scale holes embedded in electronics to enable real-time, high-performance, scalable molecular analysis, with the first use in DNA and RNA sequencing.

With a long-term goal to bring the widest benefits to society through enabling, “the analysis of anything, by anyone, anywhere”, its sequencing devices are already used by scientists in more than 120 countries around the world.

Usage includes a breadth of scientific research, the foundation for onwards applications that can solve problems in human health and food production, to tackling climate change and antimicrobial resistance.

Founded in 2005, Oxford Nanopore completed an initial public offering of shares on the London Stock Exchange in September 2021, raising gross proceeds of £428 million. As part of our Be Inspired series, CEO and co-founder, Dr Gordon Sanghera outlines why they decided to go public after 15 years, how their business is progressing after stating their key objectives from going public in 2021, the operational impact of being a public company, but also what has remained consistent.

Read the full interview here

For more inspiring business stories on building risk and seizing opportunities, visit our Future Fit Hub: Get your business fit for the future | NatWest Business